NeuroPace Inc. 8-K Filing Report - Key Insights from February 20, 2025

Based on the provided XML section of the financial report, here are the key insights extracted:
- Company Information:
- Name: NeuroPace Inc.
- CIK Number: 0001528287
- Nasdaq Ticker Symbol: NPCE
- Address: 455 N. Bernardo Avenue, Mountain View, CA 94043
- Contact Number: (650) 237-2700
- Filing Details:
- Filing Type: 8-K (this form is used to report unscheduled material events or corporate changes)
- Filing Date: February 20, 2025
- Stock Information:
- Common Stock: $0.001 par value per share
- SEC Registration:
- SEC File Number: 001-40337
- IRS Employer Identification Number (EIN): 22-3550230
- Period of Reporting:
- Reporting Date: The report covers a single day, February 20, 2025.
Insights:
- The filing is an 8-K, indicating that NeuroPace Inc. may have reported a significant event on that date, which could impact investors or stakeholders.
- The company is publicly traded on the NASDAQ under the ticker NPCE, which is essential for potential investors tracking the stock.
- The par value of the common stock is minimal ($0.001), which is common for many companies and does not typically reflect the market price of the stock.
This information provides a snapshot of NeuroPace Inc.'s corporate actions and relevant identifiers for investors and analysts looking to understand the company's current status and recent activities.